Who owns Enliven Therapeutics, Inc.?
Institutional ownership of ELVN from SEC Form 13F filings across 131 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
131
13F holders
$1.85B
value, 2026 filers
56%
of shares outstanding (40.0M sh)
37
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of ELVN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 10.0M | $508.8M | 0.0% | 14% | +46.8% |
| 2 | BlackRock, Inc. | 4.4M | $221.3M | 0.0% | 6.1% | +18.3% |
| 3 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.9M | $147,374 | 0.0% | 4.1% | +2870.8% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | $130.4M | 0.0% | 3.6% | +18.5% |
| 5 | CITADEL ADVISORS LLC | 2.1M | $105.0M | 0.0% | 2.9% | +18.6% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $71.4M | 0.0% | 2% | +32.0% |
| 7 | Pictet Asset Management Holding SA | 1.2M | $59.0M | 0.1% | 1.6% | +25.0% |
| 8 | ADAGE CAPITAL PARTNERS GP, L.L.C.NEW | 1.1M | $55.0M | 0.1% | 1.5% | new |
| 9 | SAMLYN CAPITAL, LLCNEW | 912,637 | $46.3M | 0.8% | 1.3% | new |
| 10 | Candriam S.C.A. | 905,674 | $45.9M | 0.2% | 1.3% | +52.5% |
| 11 | ALLIANCEBERNSTEIN L.P. | 896,161 | $35.1M | 0.0% | 1.3% | +16.1% |
| 12 | Balyasny Asset Management L.P. | 607,189 | $30.8M | 0.0% | 0.9% | +95.9% |
| 13 | Jupiter Topco LLCNEW | 604,122 | $30.6M | 0.0% | 0.8% | new |
| 14 | AMERICAN CENTURY COMPANIES INC | 566,165 | $28.7M | 0.0% | 0.8% | +811.5% |
| 15 | VANGUARD PORTFOLIO MANAGEMENT LLC | 562,763 | $28.6M | 0.0% | 0.8% | +70.0% |
| 16 | MARSHALL WACE, LLPNEW | 532,269 | $27.0M | 0.0% | 0.7% | new |
| 17 | MORGAN STANLEY | 509,928 | $25.9M | 0.0% | 0.7% | -1.7% |
| 18 | NORTHERN TRUST CORP | 440,938 | $22.4M | 0.0% | 0.6% | +18.4% |
| 19 | Sixth Street Partners Management Company, L.P.NEW | 424,440 | $21.5M | 3.7% | 0.6% | new |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 424,440 | $21.5M | 0.0% | 0.6% | +17.7% |
| 21 | MILLENNIUM MANAGEMENT LLC | 411,362 | $20.9M | 0.0% | 0.6% | +19.1% |
| 22 | VANGUARD FIDUCIARY TRUST CO | 383,490 | $19.5M | 0.0% | 0.5% | +22.6% |
| 23 | Nuveen, LLC | 374,217 | $19.0M | 0.0% | 0.5% | +253.4% |
| 24 | Woodline Partners LP | 347,142 | $17.6M | 0.1% | 0.5% | -42.5% |
| 25 | UBS Group AG | 342,115 | $17.4M | 0.0% | 0.5% | +20.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.